scispace - formally typeset
J

J.A. Pereira da Silva

Researcher at University of Coimbra

Publications -  38
Citations -  499

J.A. Pereira da Silva is an academic researcher from University of Coimbra. The author has contributed to research in topics: Population & Arthritis. The author has an hindex of 7, co-authored 37 publications receiving 422 citations. Previous affiliations of J.A. Pereira da Silva include Hospitais da Universidade de Coimbra.

Papers
More filters
Journal ArticleDOI

Preliminary criteria for the very early diagnosis of systemic sclerosis: results of a Delphi Consensus Study from EULAR Scleroderma Trials and Research Group

Jérôme Avouac, +127 more
TL;DR: A core set of preliminary items considered as important for the very early diagnosis of systemic sclerosis were identified in a Delphi exercise among 110 experts in the field of SSc.
Journal ArticleDOI

Septic arthritis: patients with or without isolated infectious agents have similar characteristics.

TL;DR: Synovial fluid and synovial membrane cultures more often identified pathogens compared to blood or urine cultures and response to antibiotics in septic arthritis patients.
Journal ArticleDOI

Characterization of damage in Portuguese lupus patients: analysis of a national lupus registry.

TL;DR: This large lupus cohort confirmed that demographic and clinical characteristics as well as medication are independently associated with damage and premature retirement occurs more often in patients with SDI ≥ 3, suggesting diagnosis delay might contribute to damage accrual.
Journal Article

Patients- and physicians- priorities for improvement. The case of rheumatic diseases.

TL;DR: The study showed discordance between the priorities for improvement elected by patients and by their respective physicians in RA was more pronounced in RA than in OA.
Journal ArticleDOI

Performance of SLEDAI-2K to detect a clinically meaningful change in SLE disease activity: a 36–month prospective cohort study of 334 patients:

TL;DR: SLEDAI-2K has a limited ability to detect clinically meaningful changes in SLE disease activity, failing to identify almost two-thirds of cases judged as having a clinically meaningful improvement or worsening.